Skip to main content
Log in

COVID-19 Vaccination and Reproductive Health: a Comprehensive Review for Healthcare Providers

  • General Gynecology: Review
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

With all the current misinformation on social media platforms about the COVID-19 vaccine and its potential effects on fertility, it is essential for healthcare providers to have evidenced-based research to educate their patients, especially those who are trying to conceive, of the risks to mothers and fetuses of being unvaccinated. It is well known that COVID-19 infection puts pregnant women at higher risk of complications, including ICU admission, placentitis, stillbirth, and death. In February of 2021, the American College of Obstetricians and Gynecologists (ACOG), the American Society for Reproductive Medicine (ASRM), and the Society for Maternal–Fetal Medicine (SMFM) released a statement denying any link between COVID vaccination and infertility. ASRM later confirmed and stated that “everyone, including pregnant women and those seeking to become pregnant, should get a COVID-19 vaccine”. In this review, we aim to provide a compilation of data that denies any link between vaccination and infertility for healthcare providers to be able to educate their patients based on evidence-based medicine. We also reviewed the effect of COVID-19 virus and vaccination on various parameters and processes that are essential to obtaining a successful pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Rauf A, Abu-Izneid T, Olatunde A, Ahmed Khalil A, Alhumaydhi FA, Tufail T, Shariati MA, Rebezov M, Almarhoon ZM, Mabkhot YN, Alsayari A, Rengasamy KRR. COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies. Int J Environ Res Public Health. 2020;17:8155.

  2. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing. 2022.

    Google Scholar 

  3. Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2021;39:3409–18.

    CAS  PubMed  Google Scholar 

  4. Mahase E. Covid-19: what do we know about XBB.1.5 and should we be worried? BMJ. 2023;380:153.

  5. Li F, Lu H, Zhang Q, Li X, Wang T, Liu Q, Yang Q, Qiang L. Impact of COVID-19 on female fertility: a systematic review and meta-analysis protocol. BMJ Open. 2021;11: e045524.

    PubMed  Google Scholar 

  6. Carp-Veliscu A, Mehedintu C, Frincu F, Bratila E, Rasu S, Iordache I, Bordea A, Braga M. The effects of SARS-CoV-2 infection on female fertility: A review of the literature. Int J Environ Res Public Health. 2022;19(2):984.

  7. Anderson J, Ghaffarian KR. Early pregnancy diagnosis. Treasure Island (FL): StatPearls Publishing. 2022.

  8. Martonffy AI, Rindfleisch K, Lozeau AM, Potter B. First trimester complications. Prim Care. 2012;39:71–82.

    PubMed  Google Scholar 

  9. la Cour Freiesleben N, Egerup P, Hviid KVR, Severinsen ER, Kolte AM, Westergaard D, Fich Olsen L, Prætorius L, Zedeler A, Christiansen AH, Nielsen JR, Bang D, Berntsen S, Ollé-López J, Ingham A, Bello-Rodríguez J, Storm DM, Ethelberg-Findsen J, Hoffmann ER, Wilken-Jensen C, Jørgensen FS, Westh H, Jørgensen HL, Nielsen HS. SARS-CoV-2 in first trimester pregnancy: a cohort study. Hum Reprod. 2021;36:40–7.

    CAS  PubMed  Google Scholar 

  10. Abu-Amara J, Szpecht D, Al-Saad SR, Karbowski LM. Contracting COVID-19 in the first and second trimester of pregnancy: what we know - a concise qualitative systematic review. Arch Med Sci. 2021;17:1548–57.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Bonillas CA, Feehan R. Normalizing the changes experienced during each trimester of pregnancy. J Perinat Educ. 2008;17:39–43.

    PubMed  PubMed Central  Google Scholar 

  12. Piekos SN, Roper RT, Hwang YM, Sorensen T, Price ND, Hood L, Hadlock JJ. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. Lancet Digit Health. 2022;4:e95–104.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Dalla S, Rausch M, Kellerman R. Case report: second-trimester maternal COVID-19 infection and tetralogy of fallot. Am Fam Physician. 2021;104:331.

    PubMed  Google Scholar 

  14. Joshi B, Chandi A, Srinivasan R, Saini SS, Prasad GRV, Puri GD, Bhalla A, Suri V, Bagga R. The placental pathology in Coronavirus disease 2019 infected mothers and its impact on pregnancy outcome. Placenta. 2022;127:1–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Newfield E. Third-trimester pregnancy complications. Prim Care. 2012;39:95–113.

    PubMed  Google Scholar 

  16. Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, Segal Y. Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women. JAMA. 2021;326:728–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernandez-Diaz S, Reis BY, Balicer RD. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27:1693–5.

    CAS  PubMed  Google Scholar 

  18. Halasa NB, Olson SM, Staat MA, Newhams MM, Price AM, Boom JA, Sahni LC, Cameron MA, Pannaraj PS, Bline KE, Bhumbra SS, Bradford TT, Chiotos K, Coates BM, Cullimore ML, Cvijanovich NZ, Flori HR, Gertz SJ, Heidemann SM, Hobbs CV, Hume JR, Irby K, Kamidani S, Kong M, Levy ER, Mack EH, Maddux AB, Michelson KN, Nofziger RA, Schuster JE, Schwartz SP, Smallcomb L, Tarquinio KM, Walker TC, Zinter MS, Gilboa SM, Polen KN, Campbell AP, Randolph AG, Patel MM. Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19-associated hospitalization in infants aged <6 months - 17 states, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:264–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Yang YJ, Murphy EA, Singh S, Sukhu AC, Wolfe I, Adurty S, Eng D, Yee J, Mohammed I, Zhao Z, Riley LE, Prabhu M. Association of gestational age at Coronavirus disease 2019 (COVID-19) Vaccination, history of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery. Obstet Gynecol. 2022;139:373–80.

    CAS  PubMed  Google Scholar 

  20. Shook LL, Atyeo CG, Yonker LM, Fasano A, Gray KJ, Alter G, Edlow AG. Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection. JAMA. 2022;327:1087–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Choe J, Archer JS, Shanks AL. In vitro fertilization. Treasure Island: StatPearls, StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC; 2022.

    Google Scholar 

  22. Hossein Rashidi B, Bandarian M, Bandarian F, Shahrokh Tehraninejad E, Jafarabadi M. The effect of COVID-19 Pandemic on outcome of assisted reproductive technology: a report from a single infertility center. J Family Reprod Health. 2022;16:86–92.

    PubMed  PubMed Central  Google Scholar 

  23. Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N, Broekmans F. ESHRE guideline: ovarian stimulation for IVF/ICSI(†). Hum Reprod Open. 2020;2020:hoaa009.

    PubMed  Google Scholar 

  24. Api O. Sen C, Debska M, Saccone G, D'Antonio F, Volpe N, Yayla M, Esin S, Turan S, Kurjak A, Chervenak F. Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine. J Perinat Med. 2020;48:857–866.

  25. Kumar P, Sait SF, Sharma A, Kumar M. Ovarian hyperstimulation syndrome. J Hum Reprod Sci. 2011;4:70–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Fabregues F, Peñarrubia J. Assisted reproduction and thromboembolic risk in the COVID-19 pandemic. Reprod Biomed Online. 2020;41:361–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Levi-Setti PE, Cirillo F, Scolaro V, Morenghi E, Heilbron F, Girardello D, Zannoni E, Patrizio P. Appraisal of clinical complications after 23,827 oocyte retrievals in a large assisted reproductive technology program. Fertil Steril. 2018;109(6):1038-1043.e1031.

    PubMed  Google Scholar 

  28. Vaiarelli A, Bulletti C, Cimadomo D, Borini A, Alviggi C, Ajossa S, Anserini P, Gennarelli G, Guido M, Levi-Setti PE, Palagiano A, Palermo R, Savasi V, Pellicer A, Rienzi L, Ubaldi FM. COVID-19 and ART: the view of the Italian society of fertility and sterility and reproductive medicine. Reprod Biomed Online. 2020;40:755–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Rahal D, Kozlowski IF, Rosa VBD, Schuffner A. Hemothorax after oocyte retrieval in a patient with a history of COVID-19: a case report. JBRA Assist Reprod. 2021;25:647–9.

    PubMed  PubMed Central  Google Scholar 

  30. Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456–74.

    CAS  PubMed  Google Scholar 

  31. Lee WY, Mok A, Chung JPW. Potential effects of COVID-19 on reproductive systems and fertility; assisted reproductive technology guidelines and considerations: a review. Hong Kong Med J. 2021;27:118–26.

    CAS  PubMed  Google Scholar 

  32. Khalili MA, Leisegang K, Majzoub A, Finelli R, Panner Selvam MK, Henkel R, Mojgan M, Agarwal A. Male fertility and the COVID-19 pandemic: systematic review of the literature. World J Mens Health. 2020;38:506–20.

    PubMed  PubMed Central  Google Scholar 

  33. Setti PEL, Cirillo F, Immediata V, Morenghi E, Canevisio V, Ronchetti C, Baggiani A, Albani E, Patrizio P. First trimester pregnancy outcomes in a large IVF center from the Lombardy County (Italy) during the peak COVID-19 pandemic. Sci Rep-Uk. 2021;11:16529.

    CAS  Google Scholar 

  34. Aizer A, Noach-Hirsh M, Dratviman-Storobinsky O, Nahum R, Machtinger R, Yung Y, Haas J, Orvieto R. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome. Fertil Steril. 2022;117:974–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Pellatt L, Rice S, Mason HD. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction. 2010;139:825–33.

    CAS  PubMed  Google Scholar 

  36. Pellatt L, Rice S, Mason HD. Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high?. Reproduction. 2010;139825–833.

  37. Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G, Fei C. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020;26:367–73.

    CAS  PubMed  Google Scholar 

  38. Reis FM, Bouissou DR, Pereira VM, Camargos AF, dos Reis AM, Santos RA. Angiotensin-(1–7), its receptor mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil Steril. 2011;95:176–81.

    CAS  PubMed  Google Scholar 

  39. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Anifandis G, Messini CI, Daponte A, Messinis IE. COVID-19 and fertility: a virtual reality. Reprod Biomed Online. 2020;41:157–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20:688–701.

    CAS  PubMed  Google Scholar 

  42. Mohr-Sasson A, Haas J, Abuhasira S, Sivan M, Doitch Amdurski H, Dadon T, Blumenfeld S, Derazne E, Hemi R, Orvieto R, Afek A, Rabinovici J. The effect of Covid-19 mRNA vaccine on serum anti-Mullerian hormone levels. Hum Reprod. 2022;37:534–41.

    CAS  PubMed  Google Scholar 

  43. Khoo B, Tan T, Clarke SA, Mills EG, Patel B, Modi M, Phylactou M, Eng PC, Thurston L, Alexander EC, Meeran K, Comninos AN, Abbara A, Dhillo WS. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab. 2021;106:e803–11.

    PubMed  Google Scholar 

  44. Chen M, Zhou W, Xu W. Thyroid function analysis in 50 patients with COVID-19: a retrospective study. Thyroid. 2021;31:8–11.

    CAS  PubMed  Google Scholar 

  45. Rossini A, Cassibba S, Perticone F, Benatti SV, Venturelli S, Carioli G, Ghirardi A, Rizzi M, Barbui T, Trevisan R, Ippolito S. Increased prevalence of autoimmune thyroid disease after COVID-19: a single-center, prospective study. Front Endocrinol (Lausanne). 2023;14:1126683.

    PubMed  Google Scholar 

  46. Săndulescu MS, Văduva CC, Siminel MA, Dijmărescu AL, Vrabie SC, Camen IV, Tache DE, Neamţu SD, Nagy RD, Carp-Velişcu A, Manolea MM. Impact of COVID-19 on fertility and assisted reproductive technology (ART): a systematic review. Rom J Morphol Embryol. 2022;63:503–10.

    PubMed  PubMed Central  Google Scholar 

  47. Braun AS, Feil K, Reiser E, Weiss G, von Steuben T, Pinggera GM, Köhn FM, Toth B. Corona and reproduction, or why the Corona vaccination does not result in infertility. Geburtshilfe Frauenheilkd. 2022;82:490–500.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Odeh-Natour R, Shapira M, Estrada D, Freimann S, Tal Y, Atzmon Y, Bilgory A, Aslih N, Abu-Raya YS, Shalom-Paz E. Does mRNA SARS-CoV-2 vaccine in the follicular fluid impact follicle and oocyte performance in IVF treatments? Am J Reprod Immunol. 2022;87:e13530.

  49. Ata B, Shalom-Paz E, Chian RC, Tan SL. In vitro maturation of oocytes as a strategy for fertility preservation. Clin Obstet Gynecol. 2010;53:775–86.

    PubMed  Google Scholar 

  50. Chian RC, Buckett WM, Tan SL. In-vitro maturation of human oocytes. Reprod Biomed Online. 2004;8:148–66.

    PubMed  Google Scholar 

  51. Cobo A, García-Velasco JA, Remohí J, Pellicer A. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril. 2021;115:1091–101.

    PubMed  Google Scholar 

  52. Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2015;103:303–16.

    PubMed  Google Scholar 

  53. Naji O, Moska N, Dajani Y, El-Shirif A, El-Ashkar H, Hosni MM, Khalil M, Khalaf Y, Bolton V, El-Toukhy T. Early oocyte denudation does not compromise ICSI cycle outcome: a large retrospective cohort study. Reprod Biomed Online. 2018;37:18–24.

    PubMed  Google Scholar 

  54. Nicholas C, Darmon S, Patrizio P, Albertini DF, Barad DH, Gleicher N. Changing clinical significance of oocyte maturity grades with advancing female age advances precision medicine in IVF. iScience. 2023;26:107308.

    PubMed  PubMed Central  Google Scholar 

  55. Herbert M, Surani A. Oocytes from stem cells. N Engl J Med. 2022;386:188–90.

    PubMed  Google Scholar 

  56. Keefe D, Kumar M, Kalmbach K. Oocyte competency is the key to embryo potential. Fertil Steril. 2015;103:317–22.

    PubMed  Google Scholar 

  57. Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020;114:33–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Karimian A, Behjati M, Karimian M. Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2. Arch Virol. 2022;167:1931–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Mantzourani C, Vasilakaki S, Gerogianni VE, Kokotos G. The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19. Expert Opin Drug Discov. 2022;17:231–46.

    CAS  PubMed  Google Scholar 

  60. Teixeira LMC, Coimbra JTS, Ramos MJ, Fernandes PA. Transmembrane protease serine 2 proteolytic cleavage of the SARS-CoV-2 spike protein: a mechanistic quantum mechanics/molecular mechanics study to inspire the design of new drugs to fight the COVID-19 pandemic. J Chem Inf Model. 2022;62:2510–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Bentov Y, Beharier O, Moav-Zafrir A, Kabessa M, Godin M, Greenfield CS, Ketzinel-Gilad M, Ash Broder E, Holzer HEG, Wolf D, Oiknine-Djian E, Barghouti I, Goldman-Wohl D, Yagel S, Walfisch A, Hersko Klement A. Ovarian follicular function is not altered by SARS-CoV-2 infection or BNT162b2 mRNA COVID-19 vaccination. Hum Reprod. 2021;36:2506–13.

    CAS  PubMed  Google Scholar 

  62. Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer A. Does mRNA SARS-CoV-2 vaccine influence patients’ performance during IVF-ET cycle? Reprod Biol Endocrinol. 2021;19:69.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Li K, Chen G, Hou H, Liao Q, Chen J, Bai H, Lee S, Wang C, Li H, Cheng L, Ai J. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online. 2021;42:260–7.

    CAS  PubMed  Google Scholar 

  64. Yildiz E, Timur B, Guney G, Timur H. Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve? Medicine (Baltimore). 2023;102:e33824.

  65. Kahyaoglu S, Ozaksit MG, Kahyaoglu I, Filiz AA, Pekcan MK, Atalay E, Tekin OM. Does Coronavirus disease-19 infection affect ovarian Reserve in Infertile Women? A retrospective study. J Hum Reprod Sci. 2022;15:357–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Chico-Sordo L, Polonio AM, Córdova-Oriz I, Medrano M, Herraiz S, Bronet F, García-Velasco JA, Varela E. Telomeres and oocyte maturation rate are not reduced by COVID-19 except in severe cases. Reproduction. 2022;164:259–67.

    CAS  PubMed  Google Scholar 

  67. Huang J, Guan T, Tian L, Xia L, Xu D, Wu X, Huang L, Chen M, Fang Z, Xiong C, Nie L, Wang S, Li Z, Zhao Y, Wu Q. Impact of inactivated COVID-19 vaccination on female ovarian reserve: a propensity score-matched retrospective cohort study. Front Immunol. 2023;14:1198051.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Kolanska K, Hours A, Jonquière L, Mathieu d’Argent E, Dabi Y, Dupont C, Touboul C, Antoine JM, Chabbert-Buffet N, Daraï E. Mild COVID-19 infection does not alter the ovarian reserve in women treated with ART. Reprod Biomed Online. 2021;43:1117–21.

    CAS  PubMed  PubMed Central  Google Scholar 

  69. Madendag IC, Madendag Y, Ozdemir AT. COVID-19 disease does not cause ovarian injury in women of reproductive age: an observational before-and-after COVID-19 study. Reprod Biomed Online. 2022;45:153–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Mohr-Sasson A, Haas J, Sivan M, Zehori Y, Hemi R, Orvieto R, Afek A, Rabinovici J. The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being. Arch Gynecol Obstet. 2023;307:1625–31.

    PubMed  PubMed Central  Google Scholar 

  71. Şenkaya AR, Çil Z, Keskin Ö, Güneş ME, Can Öztekin D. CoronaVac vaccine does not affect ovarian reserve. Ginekol Pol. 2023;94:298–302.

    PubMed  Google Scholar 

  72. Soysal Ç, Yılmaz E. The effect of COVID-19 vaccine on ovarian reserve. Saudi Med J. 2022;43:486–90.

    PubMed  PubMed Central  Google Scholar 

  73. Yang L, Neal S, Lee T, Chou A, Schutt AK, Gibbons W. Comparison of female ovarian reserve before vs after COVID-19 vaccination. JAMA Netw Open. 2023;6: e2318804.

    PubMed  PubMed Central  Google Scholar 

  74. Hosseini R, Askari N. A review of neurological side effects of COVID-19 vaccination. Eur J Med Res. 2023;28:102.

    PubMed  PubMed Central  Google Scholar 

  75. Aharon D, Lederman M, Ghofranian A, Hernandez-Nieto C, Canon C, Hanley W, Gounko D, Lee JA, Stein D, Buyuk E, Copperman AB. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstet Gynecol. 2022;139(4):490–7.

    CAS  PubMed  Google Scholar 

  76. Wu Y, Cao M, Lin Y, Xu Z, Liang Z, Huang Q, Li S, Li L, Meng Y, An C, Liu H, Liu J. Inactivated COVID-19 vaccination does not affect in vitro fertilization outcomes in women. Hum Reprod. 2022;37:2054–62.

    PubMed  Google Scholar 

  77. Xia W, Zhao J, Hu Y, Fang L, Wu S. Investigate the effect of COVID-19 inactivated vaccine on sperm parameters and embryo quality in in vitro fertilization. Andrologia. 2022;54: e14483.

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Reschini M, Pagliardini L, Boeri L, Piazzini F, Bandini V, Fornelli G, Dolci C, Cermisoni GC, Viganò P, Somigliana E, Coccia ME, Papaleo E. COVID-19 vaccination does not affect reproductive health parameters in men. Front Public Health. 2022;10:839967.

  79. Chen H, Zhang X, Lin G, Gong F, Hocher B. Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - clinical study and systematic review. Front Immunol. 2022;13:1054273.

    CAS  PubMed  Google Scholar 

  80. Dong M, Wu S, Zhang X, Zhao N, Qi J, Zhao D, Sang Y, Tan J. Effects of COVID-19 vaccination status, vaccine type, and vaccination interval on IVF pregnancy outcomes in infertile couples. J Assist Reprod Genet. 2022;39:1849–59.

    PubMed  PubMed Central  Google Scholar 

  81. Han AR, Lee D, Kim SK, Choo CW, Park JC, Lee JR, Choi WJ, Jun JH, Rhee JH, Kim SH, M. Korean Society for Reproductive, I. Korean Society for Reproductive, R. Korean Society for Assisted. Effects and safety of COVID-19 vaccination on assisted reproductive technology and pregnancy: a comprehensive review and joint statements of the KSRM, the KSRI, and the KOSAR. Clin Exp Reprod Med. 2022;49:2–8.

    PubMed  PubMed Central  Google Scholar 

  82. Dyer S, Chambers GM, Adamson GD, Banker M, De Mouzon J, Ishihara O, Kupka M, Mansour R, Zegers-Hochschild F. ART utilization: an indicator of access to infertility care. Reprod Biomed Online. 2020;41:6–9.

    PubMed  Google Scholar 

  83. Niederberger C, Pellicer A, Cohen J, Gardner DK, Palermo GD, O’Neill CL, Chow S, Rosenwaks Z, Cobo A, Swain JE, Schoolcraft WB, Frydman R, Bishop LA, Aharon D, Gordon C, New E, Decherney A, Tan SL, Paulson RJ, Goldfarb JM, Brännström M, Donnez J, Silber S, Dolmans MM, Simpson JL, Handyside AH, Munné S, Eguizabal C, Montserrat N, Izpisua Belmonte JC, Trounson A, Simon C, Tulandi T, Giudice LC, Norman RJ, Hsueh AJ, Sun Y, Laufer N, Kochman R, Eldar-Geva T, Lunenfeld B, Ezcurra D, D’Hooghe T, Fauser B, Tarlatzis BC, Meldrum DR, Casper RF, Fatemi HM, Devroey P, Galliano D, Wikland M, Sigman M, Schoor RA, Goldstein M, Lipshultz LI, Schlegel PN, Hussein A, Oates RD, Brannigan RE, Ross HE, Pennings G, Klock SC, Brown S, Van Steirteghem A, Rebar RW, LaBarbera AR. Forty years of IVF. Fertil Steril. 2018;110:185-324.e185.

    PubMed  Google Scholar 

  84. Etti M, Calvert A, Galiza E, Lim S, Khalil A, Le Doare K, Heath PT. Maternal vaccination: a review of current evidence and recommendations. Am J Obstet Gynecol. 2022;226:459–74.

    CAS  PubMed  Google Scholar 

  85. Facciolà A, Micali C, Visalli G, Venanzi Rullo E, Russotto Y, Laganà P, Laganà A, Nunnari G, Di Pietro A. COVID-19 and pregnancy: clinical outcomes and scientific evidence about vaccination. Eur Rev Med Pharmacol Sci. 2022;26:2610–26.

    PubMed  Google Scholar 

  86. Falsaperla R, Leone G, Familiari M, Ruggieri M. COVID-19 vaccination in pregnant and lactating women: a systematic review. Expert Rev Vaccines. 2021;20:1619–28.

    CAS  PubMed  Google Scholar 

  87. Januszek SM, Faryniak-Zuzak A, Barnaś E, Łoziński T, Góra T, Siwiec N, Szczerba P, Januszek R, Kluz T. The approach of pregnant women to vaccination based on a COVID-19 systematic review. Medicina (Kaunas). 2021;57(9):977.

  88. Kalafat E, Heath P, Prasad S, Brien PO, Khalil A. COVID-19 vaccination in pregnancy. Am J Obstet Gynecol. 2022;227:136–47.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Konje JC, Al Beloushi M, Ahmed B. Immunisation against COVID-19 in pregnancy and of women planning pregnancy. Viruses. 2023;15(3):621.

  90. Male V. SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nat Rev Immunol. 2022;22:277–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. Rasmussen SA, Jamieson DJ. COVID-19 and pregnancy. Infect Dis Clin North Am. 2022;36:423–33.

    PubMed  PubMed Central  Google Scholar 

  92. Sutton D, D’Alton M, Zhang Y, Kahe K, Cepin A, Goffman D, Staniczenko A, Yates H, Burgansky A, Coletta J, Williams Z, Gyamfi-Bannerman C. COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women. Am J Obstet Gynecol MFM. 2021;3:100403.

  93. Wang PH, Lee WL, Yang ST, Tsui KH, Chang CC, Lee FK. The impact of COVID-19 in pregnancy: part II. Vaccination to pregnant women. J Chin Med Assoc. 2021;84:903–10.

    CAS  PubMed  Google Scholar 

  94. Klipstein S, Dionne JA, Feinberg EC, Kawwass JF, Pfeifer SM, Schlegel PN, Racowsky C. Data-driven commentary on SARS-CoV-2 infection, vaccination, and fertility. Am J Epidemiol. 2022;191:1343–6.

    PubMed  Google Scholar 

  95. Charepe N, Gonçalves J, Juliano AM, Lopes DG, Canhão H, Soares H, Serrano EF. COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study. BMC Pregnancy Childbirth. 2021;21:632.

    CAS  PubMed  PubMed Central  Google Scholar 

  96. Collier AY, McMahan K, Yu J, Tostanoski LH, Aguayo R, Ansel J, Chandrashekar A, Patel S, Apraku Bondzie E, Sellers D, Barrett J, Sanborn O, Wan H, Chang A, Anioke T, Nkolola J, Bradshaw C, Jacob-Dolan C, Feldman J, Gebre M, Borducchi EN, Liu J, Schmidt AG, Suscovich T, Linde C, Alter G, Hacker MR, Barouch DH. Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women. JAMA. 2021;325:2370–80.

    CAS  PubMed  Google Scholar 

  97. Gangi R, Corrias A, Pintus R, Marcialis MA, Fanos V. What to expect from COVID-19 and from COVID-19 vaccine for expecting or lactating women. Pediatr Rep. 2022;14:262–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Garg I, Shekhar R, Sheikh AB, Pal S. COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines. Infect Dis Rep. 2021;13:685–99.

    PubMed  PubMed Central  Google Scholar 

  99. Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E, Youngster I. SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021;325:2013–4.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Katherine Palmerola or Himanshu Arora.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Disclosure Statement

Nothing to disclose.

Conflicts of Interest/Competing Interests

Authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valdes, Y., Ledesma, B., Reddy, R.V. et al. COVID-19 Vaccination and Reproductive Health: a Comprehensive Review for Healthcare Providers. Reprod. Sci. 31, 1215–1226 (2024). https://doi.org/10.1007/s43032-023-01428-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-023-01428-0

Keywords

Navigation